表紙
市場調查報告書

心律調節器/ICD (置入式除顫器) 導線系統:醫療設備的開發平台分析

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 361018
出版日期 內容資訊 英文 101 Pages
訂單完成後即時交付
價格
Back to Top
心律調節器/ICD (置入式除顫器) 導線系統:醫療設備的開發平台分析 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月17日內容資訊: 英文 101 Pages
簡介

本報告提供全球心律調節器用及置入式除顫器 (以下簡稱ICD) 導線系統市場上主要開發中產品及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,並彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 心律調節器/ICD用導線系統 (導線)的概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 心律調節器/ICD用導線系統的企業:各臨床實驗階段的開發中產品
  • 心律調節器/ICD用導線系統:各臨床實驗階段的開發中產品

第5章 心律調節器/ICD用導線系統:企業·產品概要

  • Boston Scientific Corporation
    • 開發中產品及進行中的臨床實驗概要
  • Imricor Medical Systems, Inc.
  • LivaNova PLC
  • Mayo Clinic US
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MRI Interventions, Inc
  • St. Jude Medical, Inc.
  • Teleflex Incorporated

第6章 心律調節器/ICD用導線系統:近來的市場趨勢 (全34件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0869EPD

GlobalData's Medical Devices sector report, "Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview 6

3 Products under Development 7

  • 3.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 7
  • 3.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory 8
  • 3.3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path 9
  • 3.4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date 10
  • 3.5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials 11

4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products under Development by Companies 12

  • 4.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development 12
  • 4.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 13

5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview 14

  • 5.1 Boston Scientific Corp Company Overview 14
    • 5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Mayo Clinic Company Overview 17
    • 5.2.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Medtronic plc Company Overview 19
    • 5.3.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.4 MicroPort CRM Company Overview 23
    • 5.4.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 St. Jude Medical LLC Company Overview 28
    • 5.5.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.6 Teleflex Inc Company Overview 32
    • 5.6.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 32

6 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments 33

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 33
  • 6.2 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 35
  • 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 36
  • 6.4 Nov 12, 2019: T2 Biosystems reports third quarter 2019 financial highlights and provides corporate update 37
  • 6.5 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 38

7 Appendix 98

  • 7.1 Methodology 98
  • 7.2 About GlobalData 101
  • 7.3 Contact Us 101
  • 7.4 Disclaimer 101

List of Tables

  • Table 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • Table 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
  • Table 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
  • Table 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
  • Table 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
  • Table 6: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development
  • Table 7: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status
  • Table 10: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description
  • Table 11: Next Generation ICD Lead - Product Status
  • Table 12: Next Generation ICD Lead - Product Description
  • Table 13: X4 SYSTEM + QUAD LEAD - Product Status
  • Table 14: X4 SYSTEM + QUAD LEAD - Product Description
  • Table 15: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Epicardial Pacing/sensing Lead - Product Status
  • Table 17: Epicardial Pacing/sensing Lead - Product Description
  • Table 18: Pacemaker/ICD Lead - Product Status
  • Table 19: Pacemaker/ICD Lead - Product Description
  • Table 20: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Attain Stability Quad MRI SureScan - Product Status
  • Table 22: Attain Stability Quad MRI SureScan - Product Description
  • Table 23: Medtronic plc - Ongoing Clinical Trials Overview
  • Table 24: Attain Stability Quad MRI SureScan - Attain Stability Quad Clinical Study
  • Table 25: Attain Stability Quad MRI SureScan - Personalized CRT - Attain Stability Quad Post-Approval Study
  • Table 26: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: BonaFire - Active Pacing Lead - Product Status
  • Table 28: BonaFire - Active Pacing Lead - Product Description
  • Table 29: BonaFire - Passive Pacing Lead - Product Status
  • Table 30: BonaFire - Passive Pacing Lead - Product Description
  • Table 31: Nano Lead System - Product Status
  • Table 32: Nano Lead System - Product Description
  • Table 33: SonR Tist Lead Positioning - Product Status
  • Table 34: SonR Tist Lead Positioning - Product Description
  • Table 35: SonRFix Lead - Product Status
  • Table 36: SonRFix Lead - Product Description
  • Table 37: Tachy Lead - Product Status
  • Table 38: Tachy Lead - Product Description
  • Table 39: TX Brady Lead - Product Status
  • Table 40: TX Brady Lead - Product Description
  • Table 41: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Quartet NXT - Double Blend Lead - Product Status
  • Table 43: Quartet NXT - Double Blend Lead - Product Description
  • Table 44: Quartet NXT - Large S-Curve Lead - Product Status
  • Table 45: Quartet NXT - Large S-Curve Lead - Product Description
  • Table 46: Quartet NXT - Small S-Curve Lead - Product Status
  • Table 47: Quartet NXT - Small S-Curve Lead - Product Description
  • Table 48: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Pacemaker Lead - Product Status
  • Table 50: Pacemaker Lead - Product Description
  • Table 51: Glossary

List of Figures

  • Figure 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development
  • Figure 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory
  • Figure 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path
  • Figure 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date
  • Figure 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials
Back to Top